LGALS3 and cardiomyopathy: Out of the demographic data and comorbidities of the study population, the significant predictors of galectin-3 were as follows: older age (p < 0.001), waist circumference (p = 0.003), BMI (p = 0.015), smoking (p = 0.032), presence of hypertension (p < 0.001), diabetes mellitus (p = 0.005), hypoventilation syndrome (p < 0.001), coronary disease (p < 0.001), and cardiomyopathy (p < 0.001).